Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release stays in one workspace.
STAA
$22.61
+0.80%
STAA
· Staar Surgical Co
$22.61
+0.18 (+0.80%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.03B
Shares
50.14M
Volume · Sep 30
798.87K
Avg daily vol (3M)
1.01M
All earnings calls
Earnings call · FY2025 Q2
Staar Surgical Co (STAA) Q2 2025 Earnings Call
Forward guidance
6 guided metrics
Management's latest ranges and targets are included below.
Research coverage
1 live source
Open each available source without leaving this research workspace.
Revenue
$44.32M
-55.2% YoY
Diluted EPS
-$0.34
-326.7% YoY
Gross margin
74.0%
-5.2 pp YoY
Net income
-$16.81M
-327.8% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2024.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Net sales
Raised
fiscal year 2024
|
$340M – $345M | — | $313.9M below | |
|
Adjusted EBITDA
Raised
fiscal year 2024
|
$42M | Non-GAAP | — | |
|
Adjusted EBITDA per diluted share
Raised
fiscal year 2024
|
$0.80 | Non-GAAP | — | |
|
EVO ICL sales growth in the U.S.
Initiated
fiscal year 2024
|
25% | — | — | |
|
Growth in China
Initiated
fiscal year 2024
|
10% | — | — | |
|
Adjusted EBITDA per share, diluted
2024 Outlook
|
$0.80 | Non-GAAP | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document